ULTIMED Lollipop Covid-19 Rapid Test
Item number 300
|Minimum quantity: 50||EUR 57.90||EUR 2.89 / piece|
|EUR 2.89 / piece|
|Minimum quantity: 250||EUR 57.06||EUR 2.85 / piece|
|EUR 2.85 / piece|
|Minimum quantity: 500||EUR 54.54||EUR 2.73 / piece|
|EUR 2.73 / piece|
Ulti Med Covid-19 Antigen Lollitest
Rapid test for the qualitative detection of COVID-19 antigens in human saliva.
For professional use only for in vitro diagnostics.
The ulti med COVID-19 Antigen Saliva Test is a lateral flow immunoassay for the qualitative detection of nucleocapsid protein (N-protein) antigens of 2019-nCoV in saliva samples collected directly from individuals within the first 7 days of symptom onset and suspected of having COVID-19 by their physician or healthcare provider. The test results are used to detect the nucleocapsid protein (N-protein) antigen of 2019-nCoV.
The ulti med COVID-19 Antigen Saliva Test relies on a double antibody sandwich to detect the antigen of the novel coronavirus (2019-nCoV) in saliva samples. During the test, the gold-labelled anti-2019-nCoV monoclonal antibody in the labelling pad binds to the 2019-nCoV antigen in the sample, forming a complex. This reaction complex moves along the nitrocellulose membrane during the chromatography procedure, and is detected by the anti-2019nCoV monoclonal antibody with which the nitrocellulose membrane is pre-coated in the test pad (T), and eventually a red colour reaction line forms in the T zone. If the sample does not contain 2019-nCoV antigen, no red reaction line can form in the T zone. Regardless of whether the sample to be tested contains the 2019-nCoV antigen, a red reaction line always forms in the control region (C).
Painless sample collection through saliva collection in the mouth
Higher acceptance by test persons
Higher willingness for prophylactic, frequent testing
Simple test procedure without handling, such as diluting and pipetting, with a possibly infectious sampleSuitable for minors and bedridden people as well as for people with allergies or under anaesthesia
Rapid result after 10 minutes
BfArM No. AT075/21